$ADNT stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $5,685,081 of trading volume.
Here is what we see in our data on $ADNT (you can track the company live on Quiver's $ADNT stock page):$ADNT Insider Trading Activity
$ADNT insiders have traded $ADNT stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ADNT stock by insiders over the last 6 months:
- JEROME J. DORLACK (President and CEO) sold 12,000 shares for an estimated $273,240
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ADNT Hedge Fund Activity
We have seen 137 institutional investors add shares of $ADNT stock to their portfolio, and 122 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 2,002,528 shares (-94.0%) from their portfolio in Q2 2025, for an estimated $38,969,194
- LETKO, BROSSEAU & ASSOCIATES INC added 1,481,963 shares (+inf%) to their portfolio in Q2 2025, for an estimated $28,838,999
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 1,249,176 shares (-27.8%) from their portfolio in Q2 2025, for an estimated $24,308,964
- PACER ADVISORS, INC. removed 1,124,978 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $21,892,071
- BLACKROCK, INC. added 958,115 shares (+6.5%) to their portfolio in Q2 2025, for an estimated $18,644,917
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 954,441 shares (+439.3%) to their portfolio in Q2 2025, for an estimated $18,573,421
- WOODLINE PARTNERS LP added 917,732 shares (+inf%) to their portfolio in Q2 2025, for an estimated $17,859,064
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ADNT Analyst Ratings
Wall Street analysts have issued reports on $ADNT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 09/25/2025
- B of A Securities issued a "Underperform" rating on 09/10/2025
- Stifel issued a "Buy" rating on 08/21/2025
- Morgan Stanley issued a "Underweight" rating on 08/12/2025
To track analyst ratings and price targets for $ADNT, check out Quiver Quantitative's $ADNT forecast page.
$ADNT Price Targets
Multiple analysts have issued price targets for $ADNT recently. We have seen 8 analysts offer price targets for $ADNT in the last 6 months, with a median target of $22.5.
Here are some recent targets:
- Joseph Spak from UBS set a target price of $28.0 on 10/06/2025
- Colin Langan from Wells Fargo set a target price of $31.0 on 09/25/2025
- Federico Merendi from B of A Securities set a target price of $20.0 on 09/10/2025
- Nathan Janes from Stifel set a target price of $27.0 on 08/21/2025
- Adam Jonas from Morgan Stanley set a target price of $17.0 on 08/12/2025
- Dan Levy from Barclays set a target price of $25.0 on 07/16/2025
- Michael Ward from Citigroup set a target price of $14.0 on 04/23/2025
You can track data on $ADNT on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
